HemOnc Today Current Issue

The following articles appeared in the print edition of HemOnc Today.

Table of Contents

• Amid questions about cost and access, proton therapy set for ‘big moment of change’ Ryan Lawrence
• Does proton therapy have a role in the treatment of brain tumors?
• ‘Continuous long-term education’ needed amid advances in sickle cell disease treatment Robin Pitts, RN, MN, C-FNP, CPHON
• Delaware, a state of firsts, sets new example with cancer treatment program Nicholas J. Petrelli, MD, FACS
• Data show value of crossover, rechallenge treatment with pembrolizumab for melanoma Alexandra (Sasha) Todak
• Cancer death rates continue to decline overall, but not for some common types Jennifer R. Southall
• ‘Electronic nose’ accurately detects ovarian, pancreatic cancers Jennifer R. Southall
• ‘Encouraging’ results with transurethral resection, systemic therapy for bladder cancer Mark Leiser
• Molecular tumor profiling beneficial in pediatric solid cancers Jennifer R. Southall
• Obesity linked to longer survival in metastatic castration-resistant prostate cancer Ryan Lawrence
• Olaparib well-tolerated but misses efficacy endpoint in heavily pretreated IDH-mutant high-grade glioma Ryan Lawrence
• Oncologist urges peers to share their stories of gender discrimination, harassment Talitha Bennett
• Pregnancy does not appear to affect efficacy of chemotherapy for breast cancer Alexandra (Sasha) Todak
• Alterations in ALK gene emerge as prognostic marker for neuroblastoma survival Ryan Lawrence
• ASCO updates guideline for hereditary breast cancer
• Pacritinib receives priority review for myelofibrosis with severe thrombocytopenia
• Taussig Cancer Institute appoints director of genitourinary medical oncology
• Thoracic oncologist named Winship Cancer Institute executive director
• Robotic surgery pioneer joins Mount Sinai
• Sarah Cannon appoints deputy physician-in-chief of blood cancers